GRID2 Mutation-Related Spinocerebellar Ataxia Type 18: A New Report and Literature Review

Abstract

Spinocerebellar ataxias (SCAs) are heterogeneous disorders with multiple genetic etiology. Mutations in the GRID2 gene are associated with spinocerebellar ataxia type 18 (SCA-18). We report the first Indian case of SCA-18. The proband is a 7-year-old boy with motor delay, cerebellar signs, and cerebellar atrophy. Whole exome and direct sequencing identified compound heterozygous mutations of the coding and noncoding regions of the GRID2 gene. A literature review of the published cases with pathogenic GRID2 variants was performed. Beside our patients, 32 cases were identified. The majority of reported cases were males, of consanguineous kindreds, with autosomal recessive inheritance. However, a proportion of cases (39%) had autosomal dominant/semidominant inheritance with heterozygous variants. In addition to childhood-onset cerebellar ataxia, other reported features were: early-onset dementia, complicated spastic paraparesis, retinal dystrophy, hearing loss, lower motor neuron signs, and severe global developmental delay in some homozygous cases. Cerebellar atrophy was the commonest neuroimaging finding, with few cases demonstrating brain stem, supratentorial, and white matter abnormalities. Although SCA-18 should be suspected in patients with early-onset cerebellar ataxia, eye movement abnormalities, and motor delay, clinicians should be aware of late-onset, variable presentations with pyramidal signs, dementia, and hearing loss. In suspected cases, if mutations were not detected by whole-exome sequencing, direct sequencing of noncoding regions and chromosomal microarray should be considered.

Keywords

spinocerebellar ataxia - SCA-18 - GRID2 gene - cerebellar atrophy - autosomal - semidominant inheritance

^* All the authors contributed equally and share joint first authorship.

Publikationsverlauf

Eingereicht: 31. August 2020

Angenommen: 12. Oktober 2020

Artikel online veröffentlicht:
25. November 2020

• References

• 1 Paulson HL. The spinocerebellar ataxias. J Neuroophthalmol 2009; 29 (03) 227-237
• 2 Sullivan R, Yau WY, O'Connor E, Houlden H. Spinocerebellar ataxia: an update. J Neurol 2019; 266 (02) 533-544
• 3 Buijsen RAM, Toonen LJA, Gardiner SL, van Roon-Mom WMC. Genetics, mechanisms, and therapeutic progress in polyglutamine spinocerebellar ataxias. Neurotherapeutics 2019; 16 (02) 263-286
• 4 Synofzik M, Puccio H, Mochel F, Schöls L. Autosomal recessive cerebellar ataxias: paving the way toward targeted molecular therapies. Neuron 2019; 101 (04) 560-583
• 5 Anheim M, Fleury M, Monga B. et al. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics 2010; 11 (01) 1-12
• 6 Van Schil K, Meire F, Karlstetter M. et al. Early-onset autosomal recessive cerebellar ataxia associated with retinal dystrophy: new human hotfoot phenotype caused by homozygous GRID2 deletion. Genet Med 2015; 17 (04) 291-299
• 7 Ali Z, Zulfiqar S, Klar J. et al. Homozygous GRID2 missense mutation predicts a shift in the D-serine binding domain of GluD2 in a case with generalized brain atrophy and unusual clinical features. BMC Med Genet 2017; 18 (01) 144
• 8 Coutelier M, Burglen L, Mundwiller E. et al. GRID2 mutations span from congenital to mild adult-onset cerebellar ataxia. Neurology 2015; 84 (17) 1751-1759
• 9 Sharawat IK, Saini L, Singanamala B. et al. Metabolic crisis after trivial head trauma in late-onset isolated sulfite oxidase deficiency: report of two new cases and review of published patients. Brain Dev 2020; 42 (02) 157-164
• 10 Koboldt DC, Steinberg KM, Larson DE, Wilson RK, Mardis ER. The next-generation sequencing revolution and its impact on genomics. Cell 2013; 155 (01) 27-38
• 11 Panda PK, Sharawat IK. COL6A3 mutation associated early-onset isolated dystonia (DYT)-27: report of a new case and review of published literature. Brain Dev 2020; 42 (04) 329-335
• 12 Sharawat IK, Kasinathan A, Sahu JK, Sankhyan N. Response to carbamazepine in KCNQ2 related early infantile epileptic encephalopathy. Indian J Pediatr 2019; 86 (03) 301-302
• 13 Veerapandiyan A, Enner S, Thulasi V, Ming X. A rare syndrome of GRID2 deletion in 2 siblings. Child Neurol Open 2017; 4: X17726168
• 14 Ceylan AC, Acar Arslan E, Erdem HB, Kavus H, Arslan M, Topaloğlu H. Autosomal recessive spinocerebellar ataxia 18 caused by homozygous exon 14 duplication in GRID2 and review of the literature. Acta Neurol Belg 2021; 121 (06) 1457-1462
• 15 Hills LB, Masri A, Konno K. et al. Deletions in GRID2 lead to a recessive syndrome of cerebellar ataxia and tonic upgaze in humans. Neurology 2013; 81 (16) 1378-1386
• 16 Fogel BL, Lee H, Deignan JL. et al. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol 2014; 71 (10) 1237-1246
• 17 Shamseldin HE, Maddirevula S, Faqeih E. et al. Increasing the sensitivity of clinical exome sequencing through improved filtration strategy. Genet Med 2017; 19 (05) 593-598
• 18 Utine GE, Haliloğlu G, Salanci B. et al. A homozygous deletion in GRID2 causes a human phenotype with cerebellar ataxia and atrophy. J Child Neurol 2013; 28 (07) 926-932
• 19 Maier A, Klopocki E, Horn D. et al. De novo partial deletion in GRID2 presenting with complicated spastic paraplegia. Muscle Nerve 2014; 49 (02) 289-292
• 20 Kamate M, Detroja M. Clinico-investigative profile of hereditary spastic paraplegia in children. Ann Indian Acad Neurol 2019; 22 (03) 341-344
• 21 de Souza PVS, de Rezende Pinto WBV, de Rezende Batistella GN, Bortholin T, Oliveira ASB. Hereditary spastic paraplegia: clinical and genetic hallmarks. Cerebellum 2017; 16 (02) 525-551
• 22 Vernet-der Garabedian B, Derer P, Bailly Y, Mariani J. Innate immunity in the Grid2Lc/+ mouse model of cerebellar neurodegeneration: glial CD95/CD95L plays a non-apoptotic role in persistent neuron loss-associated inflammatory reactions in the cerebellum. J Neuroinflammation 2013; 10: 65
• 23 Lalonde R, Strazielle C. Discrimination learning in Rora(sg) and Grid2(ho) mutant mice. Neurobiol Learn Mem 2008; 90 (02) 472-474
• 24 Coutelier M, Hammer MB, Stevanin G. Spastic Paraplegia and Ataxia Network. et al; Efficacy of exome-targeted capture sequencing to detect mutations in known cerebellar ataxia genes. JAMA Neurol 2018; 75 (05) 591-599